J&J’s EGFR-mutated advanced lung cancer treatment: amivantamab-vmjw plus lazertinib gains FDA approval Read more
US gives charge of facility that botched COVID vaccine to J&J, stops AstraZeneca from using the plant Read more
HC stays order asking J&J to deposit over Rs 230 cr ‘profiteered’ from sale of baby products Read more